author-photo

Francine Chen

59

Papers

561

Citations

Citation Trend

Filter By

Papers (47) Sort By

Journal Conference Others

Interplay Between Checkpoint Molecule B7-H3 and Human Leucocyte Antigen (HLA) Class I Expression: Relevance to the Clinical Course of Pancreatic Ductal Adenocarcinoma (PDAC)

2021 Journal of The American College of Surgeons
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1841: IMGC936, an investigational ADAM9-targeting antibody drug conjugate, is active against patient-derived ADAM9-expressing xenograft models

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Few-Shot Learning of an Interleaved Text Summarization Model by Pretraining with Synthetic Data

2021
Show All
- Source
- Cite
- Save
Citations (0)
Understanding Missing Links in Bipartite Networks with MissBiN.

2020 IEEE Transactions on Visualization and Computer Graphics
Show All
- Source
- Cite
- Save
Citations (2)
A Phase 1, Open-Label Study of MGD013, a Bispecific DART® Molecule Binding PD-1 and LAG-3 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
313 A phase 1 evaluation of tebotelimab, a bispecific PD-1 x LAG-3 DART® molecule, in combination with margetuximab in patients with advanced HER2+ neoplasms

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
682 Antibody-mediated blockade of interleukin-10 receptor-alpha promotes the activation of immune cells from in vitro dissociated tumor samples

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A phase I, first-in-human, open-label, dose-escalation study of MGD013, a bispecific DART molecule binding PD-1 and LAG-3, in patients with unresectable or metastatic neoplasms.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Abstract 5203: MGC018, a duocarmycin-based antibody-drug conjugate targeting B7-H3, exhibits immunomodulatory activity and enhanced antitumor activity in combination with checkpoint inhibitors

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer.

2020 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (20)